NH Korindo Sekuritas Indonesia
Menu
  • OUR SERVICE
    • News & Research
      • News
      • Equity Report
      • Research Fixed Income
      • Company Report
      • Outlook
      • Special Notation
    • Equity
    • Fixed Income
    • Margin
    • Bonds
    • Investment Banking
      • IPO
      • E-IPO
    • Wealth Management
      • Mutual Funds
    • Download Center
      • Download NAIK
      • Documents
    • Academy
      • Stock Dictionary
      • Stock Education
  • ABOUT US
    • Our Firm
    • Our People
    • Our Branch
    • Corporate Governance
    • Careers
    • FAQ
  • CONTACT
  • Register
  • EN
    • ID
  • ID
  • EN

Kalbe Farma Tbk (KLBF) Flat Growth Ahead

  • Author
  • Recent Posts
NHKSI Research Team
NHKSI Research Team
NHKSI Research Team
Latest posts by NHKSI Research Team (see all)
  • Daily Report | 27 Mar 2026 - March 27, 2026
  • Fixed Income News | Pasar SUN RI Tawarkan Cuan, Tapi Rapuh dari Sisi Risiko - March 27, 2026
  • Fixed Income News | Purbaya Tambah Rp 100T ke Bank, Tahan Lonjakan Yield Obligasi - March 26, 2026

Growth of 2.4% in Sales
KLBF’s sales grew by 2.4% from IDR4.89 trillion in 1Q17 into IDR5.01 trillion in 1Q18. The growth was boosted by the sales growth of 3.6%, 2.1%, 2.8%, and 0.5% respectively posted by the prescription drugs, the nutritional food, the distribution, and the consumer health.

Lowest Sales Growth by the Nutritional Food
Based on the Nielsen Retail data, the sales volume of dairy powder in Indonesia edged down 2.5% from 203 million tons in 2016 into 198 million tons in 2017. We estimate that the downtrend likely impacted on the nutritional food. Of note, the nutritional food posted the 1Q18 growth of 2.1% the last-5-year-lowest growth.

Download full report HERE.

Share This Article

Related Article


XA Update Report | PT Bank Central Asia Tbk. (BBCA) – Defensive and Steady Performance in a Challenging Landscape – Compelling Valuation Signals Opportunity

17 Mar 2026

BBCA closed FY25 by recording a net profit of IDR 57.5T (+4.9% YoY).

PT Industri Jamu Dan Farmasi Sido Muncul Tbk. (SIDO) – Energy Still Flowing, But Catalyst Yet to Stir

11 Mar 2026

SIDO recorded FY25 revenue growth of +4% YoY to IDR 4.08 tn (99% of our estimates), primarily supported by the F&B segment, which grew +12% YoY to IDR 1.46 tn.

XA Update Report | PT Japfa Comfeed Indonesia Tbk. (JPFA) – Strutting Record Earnings from Rising Poultry Prices

06 Mar 2026

JPFA delivered a solid revenue performance in FY25, reaching IDR 60.7 tn (+9% YoY), representing 103% of our FY25F estimates.

 

More Article

Daily Report

27 Mar 2026

Daily Report | 27 Mar 2026

The JCI extended its correction, dropping 1.89% to close at 7,164.1. The extreme volati...

READ MORE

Uncategorized

27 Mar 2026

Fixed Income News | Pasar SUN RI Tawarkan Cuan,...

Pasar Surat Utang Negara (SUN) tampaknya mulai kembali diburu investor setelah sempat t...

READ MORE

Uncategorized

26 Mar 2026

Fixed Income News | Purbaya Tambah Rp 100T ke B...

Kementerian Keuangan menambah penempatan dana sebesar Rp100 triliun ke perbankan, terma...

READ MORE

Contact Us

  • Treasury Tower 51th Floor, District 8, SCBD Lot 28, Jl. Jend. Sudirman No.Kav 52-53, RT.5/RW.3, Senayan, Kebayoran Baru, South Jakarta City, Jakarta 12190
  • cso@nhsec.co.id
  • +62 21 5088 9100 (Representative Number)
    +62 21 5088 9102 (CS Number)
  • +628 118 198 111 (Official Whatsapp 1)
    +6281 67 0000 5 (Official Whatsapp 2)

Link

  • Our Firm
  • Research
  • Our People
  • Download
  • Dictionary
  • FAQ

Certified By

Data yang ditampilkan di aplikasi PT NH Korindo Sekuritas Indonesia berasal dari BEI dan telah disetujui untuk ditampilkan.

PT NH Korindo Sekuritas Indonesia berizin dan diawasi oleh Otoritas Jasa Keuangan (OJK).


© Copyright 2026 NH Korindo Sekuritas. All rights reserved.